1[1]Dentino M,Luft FC,Yum MN,et al.Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man.Cancer,1978,41:1274-1281.
2[2]Duenas-Gonzalez A,Lopez-Graniel C,Gonzalez-Enciso A,et al.A phase Ⅱ study of multimodality treatment of locally advanced cervical cancer:neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation.Ann Oncol,2003,14:1278-1284.
3[3]Monk BJ,Alberts DS,Burger RA,et al.In vitro phase Ⅱ comparison fo the cytotoxicity of a novel platinum on fresh,human cervical cancers.Gynecol Oncol,1998,71:308-312.
5[5]Tabata T,Katoh M,Tokudome S,et al.Bioactivation of capecitabine in human liver:involvement of the cytosolic enzyme on 5'-deoxy-5-fluorocytidine formation.Drug Metab Dispos,2004,32:762-767.
6[6]Stokes Z,Symonds P,Habeshaw T,et al.Phase one dose finding study of capecitabine (Xeloda),radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer.Gynecol Oncol,2005,97:790-795.
